1120 Reg Quick Takes
BioCentury & Getty Images

Regulation

Nov. 20 Quick Takes: Approvals in Europe for Alnylam, Alexion therapies; plus FDA priority review for ADC, Sanofi and more 

Nov 21, 2020 | 12:26 AM GMT

EC approves Alnylam, Alexion therapies
Alnylam

Read the full 355 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE